Oncodesign Société Anonyme (ENXTPA:ALONC) commences share repurchases on February 5, 2021, under the program mandated by the shareholders in the Combined General Meeting held on June 25, 2020. As per the mandate, the company is authorized to repurchase up to 10% of its issued share capital. The shares will be repurchased at a price not more then €30 per share. The objective of the program is to allocate shares to employees or corporate officers of the company and French companies, as part of the participation in the fruits of business expansion, plans of share ownership or company savings plans, the stock option plan or by free allocation of shares upon the exercise of rights attached to securities giving right by refund conversion, exchange, presentation of a voucher or in any other way and promote liquidity. The repurchased shares may be transferred, sold or cancelled by way of reduction in capital. The program will be valid for a period of 18 months. As of June 25, 2020, the company had 6,818,412 shares issued and outstanding.